ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 69 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $57,000 | -61.7% | 19,873 | -43.4% | 0.01% | -65.0% |
| Q3 2021 | $149,000 | +9.6% | 35,086 | +36.4% | 0.02% | -56.5% |
| Q2 2021 | $136,000 | +40.2% | 25,718 | +23.8% | 0.05% | +48.4% |
| Q1 2021 | $97,000 | +40.6% | 20,778 | 0.0% | 0.03% | +55.0% |
| Q4 2020 | $69,000 | -59.2% | 20,778 | -59.3% | 0.02% | -63.0% |
| Q3 2020 | $169,000 | +21.6% | 51,028 | +24.0% | 0.05% | +14.9% |
| Q2 2020 | $139,000 | +13.0% | 41,148 | +28.6% | 0.05% | -9.6% |
| Q1 2020 | $123,000 | – | 32,006 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 3,662,342 | $7,874,000 | 0.16% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 213,469 | $438,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 150,914 | $309,000 | 0.04% |
| Bernardo Wealth Planning LLC | 30,469 | $62,000 | 0.03% |
| Penserra Capital Management LLC | 351,154 | $719,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,900 | $361,000 | 0.01% |
| Founders Capital Management | 3,000 | $9,000 | 0.01% |
| King Wealth Management Group | 16,000 | $33,000 | 0.01% |
| Aquatic Capital Management LLC | 1,900 | $4,000 | 0.01% |
| Newbridge Financial Services Group, Inc. | 6,075 | $12,000 | 0.01% |